Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $164000.0.

  • SeaStar Medical Holding's Change in Accured Expenses fell 3251.03% to $164000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$198000.0, marking a year-over-year decrease of 12636.48%. This contributed to the annual value of $1.9 million for FY2024, which is 26266.92% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Change in Accured Expenses is $164000.0, which was down 3251.03% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Change in Accured Expenses registered a high of $943000.0 during Q4 2024, and its lowest value of -$1.4 million during Q2 2025.
  • Its 3-year average for Change in Accured Expenses is $113727.3, with a median of $164000.0 in 2025.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first soared by 62099.45% in 2024, then tumbled by 30538.92% in 2025.
  • SeaStar Medical Holding's Change in Accured Expenses (Quarter) stood at -$181000.0 in 2023, then skyrocketed by 620.99% to $943000.0 in 2024, then tumbled by 82.61% to $164000.0 in 2025.
  • Its Change in Accured Expenses stands at $164000.0 for Q3 2025, versus -$1.4 million for Q2 2025 and $67000.0 for Q1 2025.